Covered recipient · General Payments record
MYRNELLE D FLEUR-AIME
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner
General Payments · PY2021–2024
$1,464.74
- Reported across 52 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $355.43 | 11 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Vanda Pharmaceuticals Inc. | $124.99 | 1 |
| Janssen Biotech, Inc. | $96.54 | 4 |
| TerSera Therapeutics LLC | $35.78 | 1 |
| ImmunoGen, Inc. | $24.15 | 1 |
| Coherus Biosciences Inc. | $18.84 | 1 |
| PFIZER INC. | $18.83 | 1 |
| Genentech USA, Inc. | $18.76 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $17.54 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Coherus Biosciences Inc. | $18.84 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147277694 | CMS |
| Genentech USA, Inc. | $18.76 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133178397 | CMS |
| ImmunoGen, Inc. | $24.15 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1099942041 | CMS |
| Janssen Biotech, Inc. | $22.48 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078508074 | CMS |
| Janssen Biotech, Inc. | $23.94 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078508181 | CMS |
| Janssen Biotech, Inc. | $18.59 | 07/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078508091 | CMS |
| Janssen Biotech, Inc. | $31.53 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078507811 | CMS |
| Novartis Pharmaceuticals Corporation | $17.54 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086931597 | CMS |
| PFIZER INC. | $18.83 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131306288 | CMS |
| TerSera Therapeutics LLC | $35.78 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144723151 | CMS |
| Vanda Pharmaceuticals Inc. | $124.99 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133942498 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.